Instil Bio, Inc.
TIL
$11.49
$0.716.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -44.94% | -42.49% | -26.68% | -12.22% | -10.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.30% | -5.33% | -26.42% | -5.28% | -44.85% |
| Operating Income | -33.30% | 5.33% | 26.42% | 5.28% | 44.85% |
| Income Before Tax | 40.98% | -43.42% | -16.04% | 7.97% | 65.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 40.98% | -43.42% | -16.04% | 7.97% | 65.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.98% | -43.42% | -16.04% | 7.97% | 65.86% |
| EBIT | -33.30% | 5.33% | 26.42% | 5.28% | 44.85% |
| EBITDA | -44.77% | -1.87% | 25.18% | 3.70% | 46.78% |
| EPS Basic | 43.17% | -41.40% | -15.53% | 8.28% | 65.87% |
| Normalized Basic EPS | -22.73% | 25.73% | 39.76% | 4.57% | 49.62% |
| EPS Diluted | 43.17% | -41.40% | -15.53% | 8.28% | 65.87% |
| Normalized Diluted EPS | -22.73% | 25.73% | 39.76% | 4.57% | 49.62% |
| Average Basic Shares Outstanding | 3.86% | 1.43% | 0.44% | 0.34% | 0.04% |
| Average Diluted Shares Outstanding | 3.86% | 1.43% | 0.44% | 0.34% | 0.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |